SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law
ARS PharmaceuticalsARS Pharmaceuticals(US:SPRY) Businesswire·2026-08-09 02:36

诉讼相关 - 投资者有机会领导针对ARS Pharmaceuticals公司的证券欺诈诉讼 [1] - 该诉讼由SBS Law律师事务所发起 [1] - 诉讼涉及SPRY投资者 [1]

SPRY Investors Have Opportunity to Lead ARS Pharmaceuticals, Inc. Securities Fraud Lawsuit with SBS Law - Reportify